Written answers
Tuesday, 15 January 2019
Department of Health
Medicinal Products Reimbursement
Donnchadh Ó Laoghaire (Cork South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
663. To ask the Minister for Health if the application for reimbursement of Ocrevus for persons with relapsing MS and primary progressive MS has been discussed by the HSE drugs group; if so, the decisions that were made; if these drugs will be on the agenda for the next meeting of the HSE leadership team; when persons with MS who are eligible candidates for Ocrevus can expect to have access to same; and if he will make a statement on the matter. [54511/18]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments